The Central Animal Research Facility (CARF) at RAKMHSU is established as a flagship preclinical and experimental research centre, addressing the growing national and regional demand for advanced, ethically compliant, and high-quality in vivo research infrastructure. Since its inception, CARF has evolved into one of the most sophisticated animal research facilities in the UAE, providing a critical bridge between discovery science and translational applications

The Central Animal Research Facility (CARF) at RAKMHSU is a fully licensed, MOCCAE and RAK EPDA-registered preclinical research hub, setting new standards in translational in vivo experimentation in the UAE. Designed as a BSL-2 compliant facility, CARF supports ethically conducted animal research in rats and mice across metabolic, oncologic, neurologic, cardiovascular, infectious, and toxicological domains. The centre houses EMKA and Kent non-invasive ECG/BP systems, working heart apparatus, pain and behavioral analysis units, hematology analyzer and biosafety cabinets for infectious models.

CARF’s infrastructure enables in vivo validation of novel drugs, nanoparticles, and biologics, bridging molecular mechanisms with whole-organism outcomes. Supported by trained veterinary and technical staff, the facility adheres strictly to the 3R principles (Replacement, Reduction, Refinement) and global ethical standards. CARF has positioned RAKMHSU as a national leader in preclinical innovation, fostering academic–industrial collaborations across the UAE & India.

CARF is purpose-built to support comprehensive preclinical research, including disease modeling, behavioral neuroscience, cardiovascular and metabolic studies, pharmacology, surgical innovation, and translational therapeutics. Its development reflects RAKMHSU’s commitment to global standards, scientific rigor, and innovation-driven research culture.